A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.

Cutis

Volumn 84, Issue 2, 2009, Pages 110-116

  Gold, Linda Stein ^a   Tan, Jerry ^b   Cruz Santana, Alma ^c   Papp, Kim ^d   Poulin, Yves ^e   Schlessinger, Joel ^f   Gidner, Judi ^g   Liu, Yin ^g   Graeber, Michael ^g  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b Windsor Clinical Research Inc   (Canada)

^c Grupo Dermatologico de Carolina   (Puerto Rico)

^d Clinical Research   (Canada)

^e Centre de Recherche Dermatologique du Quebec Metropolitain   (Canada)

^f Advanced Skin Research Center   (United States)

^g Galderma R and D Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; GEL; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PUERTO RICO; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ACNE VULGARIS; ADOLESCENT; ADULT; BENZOYL PEROXIDE; CANADA; CHILD; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PUERTO RICO; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 71949112592     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pawin H, Beylot C, Chivot M, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol. 2004;14:4-12.
2. Gollnick H, Cunliffe W, Berson D, et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49 (suppl 1):S1-S37.
3. Thielitz A, Krautheim A, Gollnick H. Update in retinoid therapy of acne. Dermatol Ther. 2006;19:272-279.
4. Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840-848.
5. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(suppl 6):9-25.
6. Michel S, Jomard A, Démarchez M. Pharmacology of adapalene. Br J Dermatol. 1998;139(suppl 52):3-7.
7. Tenaud I, Khammari A, Dreno B. In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol. 2007;16:500-506.
8. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292:726-735.
9. Waugh J, Noble S, Scott LJ. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs. 2004;64: 1465-1478.
10. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. J Eur Acad Dermatol Venereol. 2001;15(suppl 3):51-55.
11. Martin B, Meunier C, Montels D, et al. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol. 1998;139 (suppl 52):8-11.
12. Andres P, Pernin C, Poncet M. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Cutis. 2008;81:278-284.
13. Loesche C, Pernin C, Poncet M. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy. Eur J Dermatol. 2008; 18:524-526.
14. Thiboutot DM, Weiss J, Bucko A, et al. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007;57:791-799.
15. Pariser DM, Westmoreland P, Morris A, et al. Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris. J Drugs Dermatol. 2007; 6:899-905.
16. Wolf JE Jr, Kaplan D, Kraus SJ, et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: a multicenter, randomized, investigator-blinded study. J Am Acad Dermatol. 2003;49(suppl 3):S211-S217.
17. Thiboutot D, Shalita A, Yamauchi PS, et al. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigatorblind, randomized, controlled study. Skinmed. 2005;4: 138-146.
18. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol. 1997; 37:590-595.
19. Thiboutot D, Dréno B, Layton A. Acne counseling to improve adherence. Cutis. 2008;81:81-86.
20. Margolis DJ, Bowe WP, Hoffstad O, et al. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol. 2005;141: 1132-1136.
21. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(suppl 3):S200-S210.